Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni China
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
    • 简体中文
Menu Close
2022

Wish You Happy New Year!

Read More »
2022-12-30
2022

Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project

Read More »
2022-12-30
2022

Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association

Read More »
2022-11-11
2022

Successful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium

Read More »
2022-09-05
2022

Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics

Read More »
2022-07-11
2022

Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification

Read More »
2022-06-01
2022

New Year Greetings from Mr. Jacky Zhang!

Read More »
2022-01-31
2022

The new school building of Beroni Hope School in Garzê is officially open for use

Read More »
2022-01-21
2021

Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan

Read More »
2021-11-19
2021

Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal

Read More »
2021-10-29
All members is ready to go Pinggu district, Beijing
2021

Successful Conclusion to Beroni Group’s 2021 Team Building Activity

Read More »
2021-10-22
The 6th China BioMed Innovation and Investment Conference
2021

Beroni Group was invited to attend the 6th China BioMed Innovation and Investment Conference

Read More »
2021-09-30
2021

Beroni Group Wishing You Happy Mid-Autumn Festival!

Read More »
2021-09-18
2021

Beroni Group Announced the Latest Clinical Study of its SARS- CoV-2 Antigen Test Kit (Colloidal Gold Method)

Read More »
2021-09-01

Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO

Read More »
2021-09-01

Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

Read More »
2021-05-28
Beroni ’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)
2021

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

Read More »
2021-04-27
2021

New Year Greetings from Mr. Jacky Zhang!

Read More »
2021-02-09
2021

Wish You Happy New Year!

Read More »
2021-01-01
2020

Major Events of Beroni Group Limited in 2020

Read More »
2020-12-31
2020

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification

Read More »
2020-12-22
Beilemei
2020

Beroni Group Launches a New Probiotics Health Product in China

Read More »
2020-11-10
Certificate
2020

Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020

Read More »
2020-11-10

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19

Read More »
2020-10-21
Group photo of Beroni Group and Genscript’s R&D teams
2020

Beroni Group Collaborates with Genscript Biotech Corporation

Read More »
2020-08-17

Beroni Group to Supply COVID-19 Antibody Test Kit to Japan

Read More »
2020-07-14
Group photo of representatives of the two sides
2020

Representatives of Huarong Securities Co., Ltd Visit Beroni Group

Read More »
2020-05-29
Mr. Jacky Zhang and Mr. Duo Zheng signing the cooperation agreement
2020

Strategic Cooperation between Beroni Group and BG Health

Read More »
2020-05-19
This news has been highlighted in several online media sites
2020

Beroni Group and Tianjin University have made a significant discovery in developing a medical solution using nanobody technology for the novel coronavirus

Read More »
2020-05-19
2020

Beroni China (product: SARS-CoV-2 IgG/IgM Antibody Detection Kit) is included in the List of Medical Devices and Supplies Companies with Certification/Authorization from Other Countries

Read More »
2020-05-19
beroni logo new
2020

Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit

Read More »
2020-04-01
beroni logo new
2020

Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19)

Read More »
2020-03-13
beroni logo new
2020

Beroni Group Collaborates with Tianjin University to Develop Novel Solution for Coronavirus (COVID-19)

Read More »
2020-03-06
2020

Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA

Read More »
2020-02-14
2020

Beroni Group looking to up-list to the Nasdaq

Read More »
2020-02-05
Mr. Jacky Zhang, Executive Chairman of Beroni Group making the new year’s address
2020

Successful Conclusion to Beroni China’s 2019-2020 Work Summary Meeting & New Year’s Gala

Read More »
2020-01-08
2019

Beroni Group Wishing you Happy New Year

Read More »
2019-12-30
Group photo of special
2019

Successful Conclusion to the Third Precision Medicine & Medical Care and Aging International Forum

Read More »
2019-12-12
Beroni’s members attending the competition
2019

Beroni China Won Several Awards at Tianjin Xiqing District’s Golden Technology Innovation Project Competition

Read More »
2019-11-27
Group photo
2019

Strategic Cooperation Between Beroni Group and Capital Medica

Read More »
2019-11-14
Signing ceremony
2019

Signing Ceremony for the strategic cooperation of “Beroni Life and Health Industry Park” Project

Read More »
2019-11-05
2019

Beroni Group Wishing you Happy National Day

Read More »
2019-09-30
Mr. Wenlian Cao, President of SIFIA and Mr. Shouji Lu, Vice President of SIFIA presenting the certificate to Beroni Group
2019

The Silk-Road Industry and Finance International Alliance awarded Beroni China the “Model Work Entity” of the Healthcare Professional Committee

Read More »
2019-09-27
2019

Beroni Group is Ready to Commercialise the Diagnostic Kit for Detecting Zika, Dengue, Chikungya and West Nile Viruses

Read More »
2019-09-27
Skin Rejuvenation and Wrinkle Care Facial Masks
2019

Beroni Group Launches its First-Ever Japan-Made Regenerative Skincare Products in Chinese Consumer Market

Read More »
2019-09-27
Group photo
2019

Successful Conclusion to Beroni Group’s 2019 China-Japan Scientific and Technological Exchange Symposium

Read More »
2019-08-28
Mr. Jacky Zhang introducing Beroni Group to TAST
2019

Tianjin Association of Science and Technology’s Visit to Beroni Group

Read More »
2019-08-28
Signing of agreement
2019

Beroni Group Expands Into Strategic Relationship With Jinshui Science & Education Park In Zhengzhou, China

Read More »
2019-08-20
ISO14001 Environmental Management System Certificate (Chinese version and English version)
2019

Beroni China has achieved the ISO14001:2015 Certification

Read More »
2019-08-20
Group photo (9th June)
2019

Successful Conclusion to Beroni Group’s 2019 Scientific and Technological Strategy Symposium

Read More »
2019-08-20

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)

What’s New

  • Wish You Happy New Year!
  • Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project
  • Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association
  • Successful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium
  • Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu